BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2021 12:05:59 PM | Browse: 625 | Download: 1135
 |
Received |
|
2020-11-03 14:36 |
|
Peer-Review Started |
|
2020-11-03 14:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-11 03:34 |
|
Revised |
|
2021-01-21 02:54 |
|
Second Decision |
|
2021-02-19 13:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-02-20 04:42 |
|
Articles in Press |
|
2021-02-20 04:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-08 08:55 |
|
Publish the Manuscript Online |
|
2021-03-11 12:05 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Systemic adverse effects and toxicities associated with immunotherapy: A review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Asim Kichloo, Michael Albosta, Dushyant Dahiya, Jean Claude Guidi, Michael Aljadah, Jagmeet Singh, Hafeez Shaka, Farah Wani, Akshay Kumar and Manidhar Lekkala |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Michael Albosta, MD, Doctor, Doctor, Internal Medicine, Central Michigan University, 1000 Houghton Ave., Saginaw, MI 48603, United States. albos1ms@cmich.edu |
| Key Words |
Immunotherapy; Cancer; Malignancy; Adverse effects; Immune checkpoint inhibitor; Monoclonal antibody |
| Core Tip |
While immunotherapy is widely becoming a popular therapeutic treatment modality for a broad range of malignancies, it also has been known to cause a number of adverse effects. These effects have been found to be prevalent in a large number of organ systems. Clinicians should be aware of the various adverse effects associated with these novel therapeutic agents, as well as recommendations for management of these side effects in order to facilitate improved outcomes for patients undergoing these therapies. |
| Publish Date |
2021-03-11 12:05 |
| Citation |
Kichloo A, Albosta M, Dahiya D, Guidi JC, Aljadah M, Singh J, Shaka H, Wani F, Kumar A, Lekkala M. Systemic adverse effects and toxicities associated with immunotherapy: A review. World J Clin Oncol 2021; 12(3): 150-163 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i3/150.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i3.150 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
